Showing results (1-10 of 332) with videos related to
Sort By:
Pageof 34
Journal of Hepatology|November 21, 2008
EWI-2wint--a host cell factor inhibiting hepatitis C virus entryCatherine Schuster, Thomas F BaumertExpert Review of Proteomics|June 20, 2017
Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impactEmilie Crouchet, Thomas F Baumert, Catherine SchusterComptes Rendus Biologies|July 5, 2022
Liver cell circuits and therapeutic discovery for advanced liver disease and cancerEmilie Crouchet, Catherine Schuster, Thomas F BaumertNucleic Acids Research|April 11, 2008
The major form of hepatitis C virus alternate reading frame protein is suppressed by core protein expressionMarie Wolf, Maria Dimitrova, Thomas F Baumert, et al.Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapyMirjam B Zeisel, Heidi Barth, Catherine Schuster, et al.Viruses|November 6, 2015
Host-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionMirjam B Zeisel, Emilie Crouchet, Thomas F Baumert, et al.Virologie (Montrouge, France)|October 28, 2020
[Solute carrier NTCP, a key actor in liver infections by hepatitis viruses and a promising antiviral target]Eloi R Verrier, Laura Heydmann, Thomas F Baumert, et al.Plos One|April 23, 2014
Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein EMathieu Lefèvre, Daniel J Felmlee, Marie Parnot, et al.Therapeutic Advances in Gastroenterology|April 6, 2018
Host-targeting therapies for hepatitis C virus infection: current developments and future applicationsEmilie Crouchet, Florian Wrensch, Catherine Schuster, et al.Viruses|May 24, 2013
Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver diseaseDaniel J Felmlee, Mohamed Lamine Hafirassou, Mathieu Lefevre, et al.Pageof 34